All Relations between asymmetrical (pato 0000616) and nitrogen monoxide

Reference Sentence Publish Date Extraction Date Species
Murat Aydin, Nejat Altintas, Levent Cem Mutlu, Bulent Bilir, Mustafa Oran, Feti T\\xc3\\xbcl\\xc3\\xbcba\\xc5\\x9f, Birol Top\\xc3\\xa7u, \\xc4\\xb0smail Tayfur, Volkan K\\xc3\\xbc\\xc3\\xa7\\xc3\\xbckyal\\xc3\\xa7in, Gizem Kaplan, Ahmet G\\xc3\\xbcre. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD. The clinical respiratory journal vol 11 issue 3 2018 26076870 asymmetric dimethylarginine (adma) and nitric oxide (no) show their mechanism of action reciprocally, the balance between these molecules contributes to the tight regulation of airways tone and function. 2018-03-01 2022-01-12 Not clear
Theodoros Dimitroulas, James Hodson, Vasileios F Panoulas, Aamer Sandoo, Jacqueline Smith, George Kita. Genetic variations in the alanine-glyoxylate aminotransferase 2 (AGXT2) gene and dimethylarginines levels in rheumatoid arthritis. Amino acids vol 49 issue 6 2018 28357606 asymmetric (adma) and symmetric (sdma) dimethylarginines are endogenous inhibitors of nitric oxide synthase and have been repeatedly linked with adverse cardiovascular outcomes in the general population and various disease settings. 2018-02-23 2022-01-13 Not clear
Jun Feng, Hua-Wen Chen, Li-Juan Pi, Jin Wang, Da-Qian Zha. Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway. Oncotarget vol 8 issue 6 2018 28053285 elisa and western blotting were used to measure the serum asymmetric dimethylarginine (adma), nitric oxide (no) and cardiac troponin i (ctni) levels, and the expressions of the cys-c/wnt signaling pathway-related proteins, enos and nox4. 2018-02-20 2022-01-13 Not clear
S Lambden, D Martin, K Vanezis, B Lee, J Tomlinson, S Piper, O Boruc, M Mythen, J Leipe. Hypoxia causes increased monocyte nitric oxide synthesis which is mediated by changes in dimethylarginine dimethylaminohydrolase 2 expression in animal and human models of normobaric hypoxia. Nitric oxide : biology and chemistry vol 58 issue 2018 27319282 this study explored the metabolism of the endogenous inhibitor of nitric oxide production asymmetric dimethylarginine(adma) by monocyte dimethylarginine dimethylaminohydrolase 2(ddah2), and the role of this pathway in the regulation of the cellular response and the local environment during hypoxia. 2018-01-31 2022-01-12 Not clear
Muhammet Hulusi Sat\\xc4\\xb1lm\\xc4\\xb1\\xc5\\x9fo\\xc4\\x9flu, Vesile \\xc3\\x96rnek Diker, \\xc3\\x96mer Ta\\xc5\\x9fbulak, Mustafa Diker, Ali Birand, Mehmet Kaya, Taner \\xc4\\xb0yig\\xc3\\xbcn, Abdurrahman Eksi. Increased plasma asymmetric dimethylarginine level is associated with ascending aorta dilatation: a case-control study. Kardiologia polska vol 75 issue 10 2018 28715076 asymmetric dimethylarginine (adma) is an endogenous inhibitor of nitric oxide synthase. 2018-01-30 2022-01-13 Not clear
Roman N Rodionov, Annett Heinrich, Silke Brilloff, Natalia Jarzebska, Jens Martens-Lobenhoffer, Stefanie M Bode-B\\xc3\\xb6ger, Vladimir T Todorov, Christian P M Hugo, Norbert Weiss, Bernd Hohenstei. ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy. Atherosclerosis. Supplements vol 30 issue 2018 29096857 association studies suggest that asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthases, plays a role in the pathogenesis of diabetic nephropathy. 2018-01-29 2022-01-13 Not clear
D U Isik, A Y Bas, N Demirel, S Kavurt, O Aydemir, A V Kavurt, I Ceti. Increased asymmetric dimethylarginine levels in severe transient tachypnea of the newborn. Journal of perinatology : official journal of the California Perinatal Association vol 36 issue 6 2018 26866680 nitric oxide (no) is synthesized by no synthase (nos), and asymmetric dimethylarginine (adma) is an endogenous inhibitor of nos. 2018-01-18 2022-01-12 Not clear
P Szabo, J Lantos, L Nagy, S Keki, E Volgyi, G Menyhei, Z Illes, T Molna. l-Arginine Pathway Metabolites Predict Need for Intra-operative Shunt During Carotid Endarterectomy. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery vol 52 issue 6 2018 27839876 asymmetric dimethylarginine (adma) inhibits nitric oxide (no) synthesis and is a marker of atherosclerosis. 2018-01-08 2022-01-13 Not clear
Junji Takaya, Yuko Tanabe, Yuichi Kuroyanagi, Kazunari Kanek. Relationship between asymmetric dimethylarginine in umbilical cord plasma and birth weight follows a U-shaped curve. Endocrine journal vol 64 issue 4 2018 28302957 asymmetric dimethylarginine (adma) is a nonselective nitric oxide (no) synthase inhibitor associated with cardiovascular and metabolic disorders. 2018-01-04 2022-01-13 Not clear
Tse-Min Lu, Tzong-Shyuan Lee, Shing-Jong Lin, Wan-Leong Chan, Chiao-Po Hs. The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X. PloS one vol 12 issue 12 2017 29206850 asymmetric dimethylarginine (adma), characterized as a circulating endogenous inhibitor of nitric oxide synthase, may have been implicated as an important contributing factor for the development of endothelial dysfunction. 2017-12-29 2022-01-13 Not clear
D Winnica, L G Que, C Baffi, H Grasemann, K Fiedler, Z Yang, E Etling, K Wasil, S E Wenzel, B Freeman, F Holgui. l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol 47 issue 2 2017 27562295 l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells. 2017-12-22 2022-01-12 Not clear
Kenji Obayashi, Keigo Saeki, Taeko Maegawa, Takahide Sakai, Maiko Kitagawa, Naoto Otaki, Hiroshi Kataoka, Norio Kurumatan. Association of Serum Asymmetric Dimethylarginine With Muscle Strength and Gait Speed: A Cross-Sectional Study of the HEIJO-KYO Cohort. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research vol 31 issue 5 2017 26704561 nitric oxide (no) plays an important role in regulating physiological process in skeletal muscles; however, the association between serum asymmetric dimethylarginine (adma) level, an endogenous competitive inhibitor of no synthesis, and physical performance has not yet been studied. 2017-12-15 2022-01-12 Not clear
Haiyang Peng, Luyao Chen, Xiao Huang, Tianlun Yang, Zaixin Yu, Guangjie Cheng, Guogang Zhang, Ruizheng Sh. Vascular peroxidase 1 up regulation by angiotensin II attenuates nitric oxide production through increasing asymmetrical dimethylarginine in HUVECs. Journal of the American Society of Hypertension : JASH vol 10 issue 9 2017 27475679 asymmetric dimethylarginine (adma), the endogenous inhibitor of nitric oxide synthase, contributes to endothelial dysfunction and subsequent cardiovascular events including hypertension. 2017-12-11 2022-01-12 Not clear
Yuan-Jian Yang, Jian-Wen Xiong, Ying Zhao, Jin-Qiong Zhan, Hai-Bo Chen, Kun Yan, Mao-Rong Hu, Bin Yu, Bo We. Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia. Psychiatry research vol 246 issue 2017 27794276 previous studies have shown that plasma asymmetric dimethylarginine (adma), an endogenous inhibitor of the nitric oxide synthase, was increased in patients with schizophrenia. 2017-12-07 2022-01-13 Not clear
Alaadin V\\xc3\\xb6geli, Manuel Ottiger, Marc A Meier, Christian Steuer, Luca Bernasconi, Prasad Kulkarni, Andreas Huber, Mirjam Christ-Crain, Christoph Henzen, Claus Hoess, Robert Thomann, Werner Zimmerli, Beat Mueller, Philipp Schuet. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia. Respiratory research vol 18 issue 1 2017 28114935 during infection, there is an activation of the l-arginine-nitric-oxide pathway, with a shift from nitric oxide synthesis to a degradation of l-arginine to its metabolites, asymmetric and symmetric dimethylarginine (adma and sdma). 2017-11-30 2022-01-13 Not clear
Mei-Rong Du, Gui-Xia Ju, Nian-Sheng Li, Jun-Lin Jian. Role of Asymmetrical Dimethylarginine in Diabetic Microvascular Complications. Journal of cardiovascular pharmacology vol 68 issue 4 2017 27760067 asymmetric dimethylarginine (adma), an endogenous nitric oxide synthase inhibitor, is involved in endothelial dysfunction, oxidative stress, and inflammation associated with the progression of diabetic microvascular complications. 2017-11-27 2022-01-12 Not clear
Lucas C Pinheiro, Gustavo H Oliveira-Paula, Rafael L Portella, Danielle A Guimar\\xc3\\xa3es, Celio D de Angelis, Jose E Tanus-Santo. Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction. Redox biology vol 9 issue 2017 27521759 while ppis increase asymmetric dimethylarginine (adma) levels and inhibit nitric oxide production, it is unknown whether impaired vascular redox biology resulting of increased xanthine oxidoreductase (xor) activity mediates ppis-induced endothelial dysfunction (ed). 2017-11-21 2022-01-12 Not clear
Francesca Santilli, Andrea Boccatonda, Giovanni Dav\\xc3\\xac, Francesco Cipollon. The Coxib case: Are EP receptors really guilty? Atherosclerosis vol 249 issue 2017 27105159 moreover, nitric oxide (no) bioavailability and its relation with the endogenous nitric oxide synthase (nos) inhibitors asymmetric dimethylarginine (adma) and l-ng-monomethylarginine (l-nmma), renin release by juxtaglomerular cells and aldosterone pathway, seem to determine nsaid safety also. 2017-11-20 2022-01-12 Not clear
You-Lin Tain, Chien-Ning Hs. Toxic\\xc2\\xa0Dimethylarginines:\\xc2\\xa0Asymmetric\\xc2\\xa0 Dimethylarginine\\xc2\\xa0(ADMA)\\xc2\\xa0and\\xc2\\xa0Symmetric\\xc2\\xa0 Dimethylarginine\\xc2\\xa0(SDMA). Toxins vol 9 issue 3 2017 28272322 asymmetric and symmetric dimethylarginine (adma and sdma, respectively) are toxic, non-proteinogenic amino acids formed by post-translational modification and are uremic toxins that inhibit nitric oxide (no) production and play multifunctional roles in many human diseases. 2017-11-09 2022-01-13 Not clear
Jente Boelaert, Eva Schepers, Griet Glorieux, Sunny Eloot, Raymond Vanholder, Fr\\xc3\\xa9d\\xc3\\xa9ric Lyne. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA. Toxins vol 8 issue 5 2017 27187471 asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide (no) synthesis, and its structural isomer symmetric dimethylarginine (sdma) are uremic toxins accumulating in chronic kidney disease (ckd) patients. 2017-11-03 2022-01-12 Not clear
1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54